m6A介导的CABLES1翻译通过促进非同源末端连接修复增强肿瘤放射抗性
m6A-mediated CABLES1 translation potentiates tumor radioresistance via facilitating nonhomologous end-joining repair
Li Changzhi, Tang Xianchao, Zeng Zimi, Yang Liqian, Cao Fang, Zhu Haiyan, Zhu Liqing, Shen Jie, Bian Xiaocui, Wang Libin, Liu Yang, Mao Fengbiao, Chang De, Jiao Pengtao, Wang Haiying, Li Kailong
Journal:CELL DEATH AND DIFFERENTIATION
IF:15.4
DOI:10.1038/s41418-026-01755-0
PMID:
Published:2026-05-09
research field:表观转录组学分子肿瘤学癌症治疗学DNA损伤与修复放射生物学
Abstract
Radiotherapy is a mainstay of cancer treatment, yet its efficacy is still substantially restricted due to radioresistance. The mechanisms underlying radioresistance remain elusive, impeding drug development and therapeutics. Here, using a high-throughput random gene perturbation method based on piggyBac transposon, we screened and identified CABLES1, an adaptor protein, as a key regulator of tumor radioresistance. The function of CABLES1 in radioresistance was further validated in multiple human cell lines in vitro and a mouse xenograft model in vivo. High expression of CABLES1 is significantly correlated with radioresistance in cancer patients. Mechanistically, CABLES1 interacts with XRCC6/XRCC5 heterodimer and activates DNA-PKcs by promoting DNA-PK holoenzyme formation, thus facilitating the efficiency of nonhomologous end-joining (NHEJ) repair and radioresistance. Notably, YTHDF1 recognizes METTL14-deposited m 6 A modification on CABLES1 mRNA to enhance its translation in response to ionizing radiation (IR), thereby sustaining the elevation of NHEJ repair capacity and radioresistance. Through high-throughput screening of a small molecule library, we showed that theaflavin 3,3'-digallate (TF-3) specifically disrupts the CABLES1-XRCC6 interaction, thereby sensitizing cancer cells to radiotherapy. Together, our study unveils the molecular mechanism by which CABLES1 potentiates tumor radioresistance, providing a novel synthetic lethal strategy for targeting cancer.
本文使用的Yeasen产品
南美超级胎牛血清999尝鲜特惠


